Health Catalyst’s (HCAT) Equal Weight Rating Reiterated at Wells Fargo & Company

Wells Fargo & Company restated their equal weight rating on shares of Health Catalyst (NASDAQ:HCAT) in a research note issued to investors on Wednesday, MarketBeat Ratings reports. The brokerage currently has a $1.00 price target on the stock, down from their previous price target of $5.00.

HCAT has been the subject of several other reports. Cantor Fitzgerald cut their target price on shares of Health Catalyst from $4.00 to $3.00 and set a “neutral” rating for the company in a research note on Friday, March 13th. Weiss Ratings restated a “sell (e+)” rating on shares of Health Catalyst in a research report on Monday, December 29th. Canaccord Genuity Group reduced their target price on Health Catalyst from $5.00 to $2.00 and set a “buy” rating on the stock in a report on Friday, March 13th. Stephens decreased their target price on Health Catalyst from $3.50 to $2.00 and set an “equal weight” rating on the stock in a research report on Friday, March 13th. Finally, Citigroup dropped their price target on Health Catalyst from $2.75 to $1.75 and set a “neutral” rating for the company in a research note on Friday, March 13th. Four equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $2.80.

Health Catalyst Stock Performance

NASDAQ HCAT opened at $1.23 on Wednesday. The company has a quick ratio of 1.89, a current ratio of 1.89 and a debt-to-equity ratio of 0.62. Health Catalyst has a twelve month low of $1.04 and a twelve month high of $5.06. The business has a 50-day moving average price of $1.93 and a 200-day moving average price of $2.49. The firm has a market cap of $90.51 million, a price-to-earnings ratio of -0.48 and a beta of 1.76.

Health Catalyst (NASDAQ:HCAT) last posted its quarterly earnings results on Thursday, March 12th. The company reported $0.08 EPS for the quarter, missing analysts’ consensus estimates of $0.10 by ($0.02). Health Catalyst had a negative return on equity of 4.30% and a negative net margin of 57.20%.The business had revenue of $74.68 million during the quarter, compared to analysts’ expectations of $73.99 million. As a group, equities research analysts predict that Health Catalyst will post -0.33 EPS for the current fiscal year.

Institutional Investors Weigh In On Health Catalyst

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. First Light Asset Management LLC raised its position in Health Catalyst by 17.2% during the second quarter. First Light Asset Management LLC now owns 12,230,181 shares of the company’s stock worth $46,108,000 after acquiring an additional 1,793,374 shares during the period. Millennium Management LLC grew its position in shares of Health Catalyst by 2,513.3% in the third quarter. Millennium Management LLC now owns 1,589,536 shares of the company’s stock valued at $4,530,000 after purchasing an additional 1,528,710 shares during the period. RA Capital Management L.P. purchased a new stake in shares of Health Catalyst during the fourth quarter worth about $1,897,000. HighMark Wealth Management LLC increased its stake in shares of Health Catalyst by 139.0% during the fourth quarter. HighMark Wealth Management LLC now owns 741,482 shares of the company’s stock worth $1,772,000 after purchasing an additional 431,200 shares in the last quarter. Finally, Nepsis Inc. raised its position in shares of Health Catalyst by 26.6% during the 4th quarter. Nepsis Inc. now owns 1,915,794 shares of the company’s stock worth $4,579,000 after purchasing an additional 402,762 shares during the last quarter. Hedge funds and other institutional investors own 85.00% of the company’s stock.

About Health Catalyst

Health Catalyst (NASDAQ: HCAT) is a healthcare data and analytics technology company founded in 2008 and headquartered in Salt Lake City, Utah. The company went public in 2019 and has since focused on delivering a unified data platform that helps healthcare organizations aggregate and analyze clinical, financial and operational information.

The core of Health Catalyst’s offering is the Data Operating System (DOS), a modular data management platform that integrates disparate data sources—from electronic health records to claims and patient-generated data—into a single analytics environment.